scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S0006-2952(98)00153-1 |
P698 | PubMed publication ID | 9802316 |
P2093 | author name string | C Szabó | |
G Haskó | |||
P2860 | cites work | Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen | Q21999034 |
Interleukin 1 is processed and released during apoptosis | Q24315035 | ||
Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes | Q70850648 | ||
Propranolol and the treatment of rheumatoid arthritis | Q71154388 | ||
Regulation of interleukin-10 production by beta-adrenergic agonists | Q71785361 | ||
Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice | Q71825959 | ||
Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis | Q71941662 | ||
Demonstration that circulating human blood cells have no detectable alpha-adrenergic receptors by radioligand binding analysis | Q72402542 | ||
The beta 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats | Q72417480 | ||
Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats | Q72556734 | ||
Anti-inflammatory activity of salmeterol: down-regulation of cytokine production | Q72611641 | ||
Sympathetic innervation of murine thymus and spleen: A comparative histofluorescence study | Q72643359 | ||
Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release | Q72738595 | ||
Calcium entry blockers increase interleukin-10 production in endotoxemia | Q73246769 | ||
Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice | Q73371428 | ||
Intestinal formation of hypoxanthine and uric acid during endotoxemia | Q73626602 | ||
Neural-immune interactions in health and disease | Q73923416 | ||
Effect of the phosphodiesterase III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774.1 macrophages | Q74213113 | ||
Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent | Q74375599 | ||
Evidence for adenosine triphosphate degradation in critically-ill patients | Q93630909 | ||
Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia | Q28379481 | ||
Beta 2-adrenergic mechanisms in experimental arthritis | Q33583226 | ||
Neuroendocrine-immune system interactions and autoimmunity | Q34300053 | ||
Beta-adrenoceptor-mediated effects in rat cultured thymic epithelial cells | Q35025949 | ||
Protection of mice from endotoxic death by 2-methylthio-ATP | Q35547554 | ||
Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. | Q35549648 | ||
Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids | Q36364555 | ||
Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin | Q36376502 | ||
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia | Q37351701 | ||
Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression | Q37365553 | ||
Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. | Q37372633 | ||
Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells | Q37443977 | ||
Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat. | Q37510757 | ||
Neural release of ATP and adenosine | Q38036958 | ||
Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. | Q39860320 | ||
The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death | Q40380348 | ||
Catecholamine influences and sympathetic neural modulation of immune responsiveness | Q40436974 | ||
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation | Q40506162 | ||
Adenosine, an endogenous anti-inflammatory agent | Q40749398 | ||
Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides | Q40768521 | ||
Isoproterenol inhibits Il-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages | Q41069663 | ||
Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes | Q41097610 | ||
Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells | Q41170455 | ||
Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha | Q41173412 | ||
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium | Q41240566 | ||
Inhibition of human monocyte TNF production by adenosine receptor agonists | Q41579514 | ||
Modulation of immune cell function by the autonomic nervous system | Q41615063 | ||
Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones | Q41784037 | ||
Concentration of purine compounds in the cerebrospinal fluid of infants suffering from sepsis, convulsions and hydrocephalus. | Q42557430 | ||
Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. | Q42930229 | ||
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production | Q42942780 | ||
Epinephrine exacerbates arthritis by an action at presynaptic B2-adrenoceptors | Q43427675 | ||
High-dose epinephrine acts at α2-adrenoceptors to suppress experimental arthritis | Q44793116 | ||
Enhancement of the murine primary antibody response by phenylephrine in vitro | Q44918051 | ||
Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice | Q47750973 | ||
Calcium channel blockers and dantrolene differentially regulate the production of interleukin-12 and interferon-gamma in endotoxemic mice. | Q47830248 | ||
Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice | Q49172318 | ||
Arterial baroreflexes are not essential in mediating sympathoadrenal activation in conscious endotoxic rats | Q50176448 | ||
Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. | Q53801070 | ||
Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide. | Q54576177 | ||
Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: adenosine dependent and independent mechanisms | Q57731064 | ||
Changes in Blood Hormone Levels during the Immune Response | Q67359758 | ||
The effect of norepinephrine on endotoxin-mediated macrophage activation | Q67912016 | ||
Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen | Q68332867 | ||
Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs | Q68624470 | ||
The beta 2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG) | Q70559506 | ||
Autonomic nervous system innervation of thymic-related lymphoid tissue in wildtype and nude mice | Q70621600 | ||
Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus | Q70825200 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1079-1087 | |
P577 | publication date | 1998-11-01 | |
P1433 | published in | Biochemical Pharmacology | Q864229 |
P1476 | title | Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system | |
P478 | volume | 56 |
Q24675140 | ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages |
Q43908828 | Acute cold/restraint stress inhibits host resistance to Listeria monocytogenes via beta1-adrenergic receptors |
Q61443928 | Acute tobacco smoke exposure exacerbates the inflammatory response to corneal wounds in mice via the sympathetic nervous system |
Q34043933 | Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation |
Q77581681 | An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice |
Q28583909 | Antagonism of alpha2A-adrenoceptor: a novel approach to inhibit inflammatory responses in sepsis |
Q43962579 | Association between the phenylethanolamine N-methyltransferase gene and multiple sclerosis |
Q42576755 | Autonomic dysfunction and risk stratification assessed from heart rate pattern |
Q37686937 | Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition |
Q28221337 | C-reactive protein and vulnerability to mental stress-induced myocardial ischemia |
Q81165687 | Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling |
Q35077035 | Catecholamines, sympathetic innervation, and immunity |
Q26744762 | Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems |
Q37445966 | Current status and challenges of cytokine pharmacology. |
Q34221106 | Cytokines and the central nervous system |
Q64897408 | Dopamine Receptor D5 Signaling Plays a Dual Role in Experimental Autoimmune Encephalomyelitis Potentiating Th17-Mediated Immunity and Favoring Suppressive Activity of Regulatory T-Cells. |
Q43845622 | Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism |
Q26749247 | Exercise as an Adjuvant Therapy for Hematopoietic Stem Cell Mobilization |
Q28369430 | Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism |
Q24673814 | Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase C |
Q37223680 | Gender differences in stimulated cytokine production following acute psychological stress |
Q33716470 | IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses |
Q27027311 | Influence of physical activity and nutrition on obesity-related immune function |
Q34520643 | Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes |
Q44282637 | Is β-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage? |
Q51373463 | Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. |
Q37296981 | Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins |
Q42599914 | Neural pathways in allergic inflammation |
Q37229766 | New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC. |
Q35739874 | Norepinephrine and Epinephrine Enhanced the Infectivity of Enterovirus 71. |
Q37330081 | Norepinephrine and adenosine-5'-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells |
Q33442838 | Pivotal role of the alpha(2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis |
Q37530782 | Psychosocial stress and liver disease status. |
Q38263455 | Purinergic signalling and immune cells |
Q34431888 | Receptor-mediated interaction between the sympathetic nervous system and immune system in inflammation |
Q28544866 | Role of the sympathetic nervous system in carbon tetrachloride-induced hepatotoxicity and systemic inflammation |
Q24655330 | Shaping of monocyte and macrophage function by adenosine receptors |
Q58700910 | Spotlight on cervical vagus nerve stimulation for the treatment of primary headache disorders: a review |
Q37402368 | Staphylococcus aureus synthesizes adenosine to escape host immune responses |
Q38661731 | Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression |
Q44225648 | Suppression of host resistance to Listeria monocytogenes by acute cold/restraint stress: lack of direct IL-6 involvement |
Q35028016 | Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists |
Q90529594 | Targeting of G-protein coupled receptors in sepsis |
Q30477474 | The A2B adenosine receptor protects against inflammation and excessive vascular adhesion |
Q55026693 | The Cholinergic and Adrenergic Autocrine Signaling Pathway Mediates Immunomodulation in Oyster Crassostrea gigas. |
Q64948002 | The Neuroscience of Nonpharmacological Traditional Chinese Therapy (NTCT) for Major Depressive Disorder: A Systematic Review and Meta-Analysis. |
Q36426796 | The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice |
Q44403155 | The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis |
Q34520745 | The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation |
Q43690393 | The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production |
Q37286866 | The role of stress mediators in modulation of cytokine production by ethanol |
Q35743638 | Trends in the development of new antidepressants. Is there a light at the end of the tunnel? |
Search more.